Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases
Authors
Keywords
-
Journal
Advances in Rheumatology
Volume 60, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-09
DOI
10.1186/s42358-020-00134-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
- (2020) Eva Schrezenmeier et al. Nature Reviews Rheumatology
- 2019 Update of the Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the management of lupus nephritis
- (2020) Antonis Fanouriakis et al. ANNALS OF THE RHEUMATIC DISEASES
- Characterizing the adverse dermatologic effects of hydroxychloroquine: A systematic review
- (2020) Ajay N. Sharma et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Safety management in treatment with antimalarials in rheumatology. Interdisciplinary recommendations on the basis of a systematic literature review
- (2020) C. Fiehn et al. ZEITSCHRIFT FUR RHEUMATOLOGIE
- EULAR recommendations for the management of antiphospholipid syndrome in adults
- (2019) Maria G Tektonidou et al. ANNALS OF THE RHEUMATIC DISEASES
- 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
- (2019) Antonis Fanouriakis et al. ANNALS OF THE RHEUMATIC DISEASES
- Brazilian recommendations on the safety and effectiveness of the yellow fever vaccination in patients with chronic immune-mediated inflammatory diseases
- (2019) Gecilmara Salviato Pileggi et al. Advances in Rheumatology
- Hydroxychloroquine Blood Levels Predict Hydroxychloroquine Retinopathy
- (2019) Michelle Petri et al. Arthritis & Rheumatology
- EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies
- (2019) Manuel Ramos-Casals et al. ANNALS OF THE RHEUMATIC DISEASES
- Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature
- (2018) Clotilde Chatre et al. DRUG SAFETY
- Hydroxychloroquine for the prevention of fetal growth restriction and prematurity in lupus pregnancy: A systematic review and meta-analysis
- (2018) Vivien Guillotin et al. JOINT BONE SPINE
- Antimalarial-induced Cardiomyopathy in Systemic Lupus Erythematosus: As Rare as Considered?
- (2018) Konstantinos Tselios et al. JOURNAL OF RHEUMATOLOGY
- Hydroxychloroquine retinopathy — implications of research advances for rheumatology care
- (2018) April Jorge et al. Nature Reviews Rheumatology
- Hydroxychloroquine retinopathy
- (2017) I H Yusuf et al. EYE
- Favorable effects of hydroxychloroquine on serum low density lipid in patients with systemic lupus erythematosus: A systematic review and meta-analysis
- (2017) Hamayon Babary et al. International Journal of Rheumatic Diseases
- Hydroxychloroquine-induced hyperpigmentation in systemic diseases: prevalence, clinical features and risk factors: a cross-sectional study of 41 cases
- (2017) E Bahloul et al. LUPUS
- EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome
- (2016) L Andreoli et al. ANNALS OF THE RHEUMATIC DISEASES
- Hydroxychloroquine in systemic lupus erythematosus (SLE)
- (2016) C. Ponticelli et al. Expert Opinion On Drug Safety
- Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision)
- (2016) Michael F. Marmor et al. OPHTHALMOLOGY
- 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
- (2015) Jasvinder A. Singh et al. ARTHRITIS CARE & RESEARCH
- Recomendações para o tratamento da síndrome de Sjögren
- (2015) Valéria Valim et al. Revista Brasileira De Reumatologia
- Consenso da Sociedade Brasileira de Reumatologia para o diagnóstico, manejo e tratamento da nefrite lúpica
- (2015) Evandro Mendes Klumb et al. Revista Brasileira De Reumatologia
- Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
- (2014) Ronald F van Vollenhoven et al. ANNALS OF THE RHEUMATIC DISEASES
- Hydroxychloroquine: A multifaceted treatment in lupus
- (2014) Nathalie Costedoat-Chalumeau et al. PRESSE MEDICALE
- Chloroquine: Modes of action of an undervalued drug
- (2013) Rodolfo Thomé et al. IMMUNOLOGY LETTERS
- The Early Protective Effect of Hydroxychloroquine on the Risk of Cumulative Damage in Patients with Systemic Lupus Erythematosus
- (2013) P. S. Akhavan et al. JOURNAL OF RHEUMATOLOGY
- Hydroxychloroquine-Induced Pigmentation in Patients With Systemic Lupus Erythematosus
- (2013) Moez Jallouli JAMA Dermatology
- Maternal autoantibody levels in congenital heart block and potential prophylaxis with antiinflammatory agents
- (2012) Robert D. Tunks et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Predictors of organ damage in systemic lupus erythematosus: The Hopkins Lupus Cohort
- (2012) Michelle Petri et al. ARTHRITIS AND RHEUMATISM
- Maternal Use of Hydroxychloroquine Is Associated With a Reduced Risk of Recurrent Anti-SSA/Ro-Antibody–Associated Cardiac Manifestations of Neonatal Lupus
- (2012) Peter M. Izmirly et al. CIRCULATION
- Late-Onset Systemic Lupus Erythematosus
- (2012) Laurent Arnaud et al. DRUGS & AGING
- Hydroxychloroquine reduces low-density lipoprotein cholesterol levels in systemic lupus erythematosus: a longitudinal evaluation of the lipid-lowering effect
- (2012) E Cairoli et al. LUPUS
- American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis
- (2012) Bevra H. Hahn et al. ARTHRITIS CARE & RESEARCH
- Antimalarial treatment may have a time-dependent effect on lupus survival: Data from a multinational Latin American inception cohort
- (2010) Samuel K. Shinjo et al. ARTHRITIS AND RHEUMATISM
- The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus
- (2010) Hyejung Jung et al. ARTHRITIS AND RHEUMATISM
- Hydroxychloroquine and Glycemia in Women with Rheumatoid Arthritis and Systemic Lupus Erythematosus
- (2010) S. K. PENN et al. JOURNAL OF RHEUMATOLOGY
- Drug-Induced QT-Interval Prolongation: Considerations for Clinicians
- (2010) Edward C Li et al. PHARMACOTHERAPY
- Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies
- (2009) Maria G. Tektonidou et al. ARTHRITIS AND RHEUMATISM
- Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort
- (2009) Guillermo J. Pons-Estel et al. ARTHRITIS AND RHEUMATISM
- Treatment of lupus skin involvement with quinacrine and hydroxychloroquine
- (2009) I Cavazzana et al. LUPUS
- Predictors of major infections in systemic lupus erythematosus
- (2009) Guillermo Ruiz-Irastorza et al. ARTHRITIS RESEARCH & THERAPY
- Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review
- (2008) G Ruiz-Irastorza et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort
- (2008) R Kaiser et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta-analysis of observational studies
- (2008) J. Antonio Aviña-Zubieta et al. ARTHRITIS AND RHEUMATISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation